section name header

Basics

DESCRIPTION navigator

Pregnancy Considerations navigator

Not a contraindication to pregnancy. However, arrhythmias are sometimes exacerbated by pregnancy, especially if electrolyte disturbances develop.

EPIDEMIOLOGY navigator

Prevalence depends on population studied, especially on what drugs are used in the population. All age groups can be affected, although presentation of the congenital form occurs more often in the younger age group and presentation of the acquired form in older patients after drug administration.

RISK FACTORS navigator

ETIOLOGY

OTHER navigator

COMMONLY ASSOCIATED CONDITIONS navigator

None are known in the congenital form. For the acquired form, patients are usually treated with a QT-prolonging drug for a specific medical problem.


Outline

Diagnosis

Signs and symptoms:

DIAGNOSTIC TESTS & INTERPRETATION navigator

Lab navigator

None for general use, although genetic screening is done in a research context

DIFFERENTIAL DIAGNOSIS navigator


Outline

Medication (Drugs)

Treatment

ADDITIONAL TREATMENT

General Measures navigator

SURGERY navigator

see topic on Long QT syndrome for congenital variety.

IN-PATIENT CONSIDERATIONS

Admission Criteria navigator


Outline

Ongoing Care

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring navigator

PATIENT EDUCATION navigator

PROGNOSIS navigator

In the acquired form, outcome is generally good if precipitating causes are avoided. see topic on Long QT syndrome regarding congenital form.


Outline

Miscellaneous

CODES

ICD9

427.1Paroxysmal ventricular tachycardia

SNOMED

Reference(s)

ADDITIONAL READING

Author(s)

Peter Ott

Andrew E. Epstein